Fig. S1. Representative immunohistochemical staining for versican in gastric GIST.

Fig. S2. Representative immunohistochemical staining for CD9 in gastric GIST.

Fig. S3. Versican and CD9 expressions in primary intestinal GIST and in patients’ prognosis.

Table S1. RT-PCR primers.

Table S2. Downregulated and upregulated genes in metastatic liver tumors.

Table S3. Gene ontology.

Table S4. Clinicopathological features of primary intestinal GIST and metastatic liver GIST.

Table S5. Relationship between clinicopathological factors and postoperative disease-free survival in 29 intestinal GIST patients.

CAS_1872_sm_FigsS1-3.pdf446KSupporting info item
CAS_1872_sm_TablesS1-5.xls119KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.